Assessment of Cardiovascular Disease Among Predominantly Black Gout Patients

被引:0
|
作者
Chandrakumar, Harshith Priyan [1 ]
Puskoor, Anoop Venkat [1 ]
Chillumuntala, Seeta [1 ]
Sharif, Sara [1 ]
Mora, Diego Cepeda [1 ]
Gupta, Tanuj [1 ]
Tadayoni, Ashkan [1 ]
Zonnoor, Seyedeh Leila [1 ]
Celiker, Pelin [2 ]
Yakoubovitch, Stephanie [2 ]
Tsai, Andrew [2 ]
Chiu, Courtney [2 ]
Kazi, Anan [2 ]
Freilich, Michael [2 ]
Saleh, Ahmad [2 ]
Moon, Seung Jae [2 ]
Cruickshank, Kingsley [2 ]
Li, Shuojohn [2 ]
Katz, Julie [2 ]
Eichler, Joanna [2 ]
Salciccioli, Louis [3 ]
McFarlane, Isabel M. [1 ,4 ]
机构
[1] SUNY Downstate Hlth Sci Univ, Dept Internal Med, Brooklyn, NY 11203 USA
[2] SUNY Downstate Hlth Sci Univ, Coll Med, Brooklyn, NY USA
[3] SUNY Downstate Hlth Sci Univ, Dept Cardiol, Brooklyn, NY USA
[4] SUNY Downstate Hlth Sci Univ, Dept Med, 450 Clarkson Ave, POB 50, Brooklyn, NY 11203 USA
关键词
gout; cardiovascular disease; heart failure; mortality; uric acid; SERUM URIC-ACID; RHEUMATOID-ARTHRITIS; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DIAGNOSTIC RULE; HEART-FAILURE; PRIMARY-CARE; RISK; ECHOCARDIOGRAPHY; RECOMMENDATIONS;
D O I
10.1097/RHU.0000000000001948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Although the association between gout and cardiovascular disease (CVD) has been extensively studied, scarce data are available for the Black population. We aimed to assess the association between gout and CVD in a predominantly Black urban population with gout. Methods: A cross-sectional analysis was performed between a gout cohort and an age-/sex-matched control group. Clinical parameters and 2D echocardiograms were reviewed for the patients with gout and heart failure (HF). The primary outcome studied includes the prevalence and strength of association between gout and CVD. Secondary outcomes studied includes strength of association of gout and HF categorized by ejection fraction, mortality, and HF readmissions. Results: Four hundred seventy-one patients with gout had a mean age of 63.7 +/- 0.5 years; 89% were Black, 63% were men, and mean body mass index was 31.3 +/- 0.4 kg/m(2). Hypertension, diabetes mellitus, and dyslipidemia were present in 89%, 46%, and 52%, respectively. Compared with controls, patients with gout had significantly higher rates of angina, arrhythmia, coronary artery disease/stents, myocardial infarction, coronary artery bypass graft surgery, cerebrovascular accident, and peripheral vascular disease. The adjusted odds ratio for CVD was 2.9 (95% confidence interval, 1.9-4.5; p < 0.001). Gout patients had a higher prevalence of HF with 45% (n = 212) compared with controls with 9.4% (n = 44). Adjusted odds ratio for HF risk was 7.1 (95% confidence interval, 4.7-10.6; p < 0.01). Conclusions: Gout in a predominantly Black population confers 3 times the CVD risk and 7 times HF-specific risk compared with age- and sex-matched cohort. Further research is needed to confirm our findings and to develop interventions to reduce morbidity associated with gout.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 50 条
  • [1] Assessment of Cardiovascular Disease and Mortality Among Black Patients with Gout
    Chandrakumar, Harshith P.
    Puskoor, Anoop V.
    Chillumuntala, Seeta
    Sharif, Sara
    Mora, Diego Cepeda
    Gupta, Tanuj
    Tadayoni, Ashkan
    Celiker, Pelin
    Yakoubovitch, Stephanie
    Tsai, Andrew
    Chiu, Courtney
    Kazi, Anan
    Frielich, Michael
    Saleh, Ahmad
    Moon, Seung Jae
    Cruickshank, Kingsley
    Katz, Julie
    Salciccioli, Louis
    McFarlane, Isabel M.
    CIRCULATION, 2021, 144
  • [2] Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease
    Smiyan, S. I.
    Danchak, S. V.
    PATHOLOGIA, 2015, (03): : 36 - 40
  • [3] Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout
    Cipolletta, Edoardo
    Tata, Laila J.
    Nakafero, Georgina
    Avery, Anthony J.
    Mamas, Mamas A.
    Abhishek, Abhishek
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (05): : 440 - 450
  • [4] Prevalence of Cardiovascular Disease in Patients with Gout, Osteoarthritis or Both
    Bang, Daisy
    Xu, Jinfeng
    Keenan, Robert T.
    Pike, Virginia
    Lehmann, Aaron
    Tenner, Craig T.
    Crittenden, Daria
    Pillinger, Michael H.
    Krasnokutsky, Svetlana
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] LIFESTYLE MODIFICATION FOR THE PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH GOUT
    Jung, S. M.
    Kim, K. J.
    Yun, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 518 - 518
  • [6] Cardiovascular Disease Prevalence in Patients with Osteoarthritis, Gout, or Both
    Bang, Daisy H.
    Xu, Jinfeng
    Keenan, Robert T.
    Pike, Virginia C.
    Lehmann, Robert A.
    Tenner, Craig
    Crittenden, Daria B.
    Pillinger, Michael H.
    Krasnokutsky, Svetlana
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2016, 74 (02): : 113 - 118
  • [7] ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH GOUT BY A COMPLEX MULTIMODAL ULTRASONOGRAPHY
    Gancheva, Rada
    Kundurdjiev, Atanas
    Ivanova, Mariana
    Kundurzhiev, Todor
    Kolarov, Zlatimir
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2014, 67 (09): : 1301 - 1310
  • [8] GOUT AND CARDIOVASCULAR-DISEASE
    WINOCOUR, PD
    TURNER, MR
    TAYLOR, TG
    MUNDAY, KA
    LANCET, 1977, 1 (8018): : 959 - 960
  • [9] Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease
    Pagidipati, Neha J.
    Clare, Robert M.
    Keenan, Robert T.
    Chiswell, Karen
    Roe, Matthew T.
    Hess, Connie N.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (16):
  • [10] Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure
    Mouradjian, Mallory T.
    Plazak, Michael E.
    Gale, Stormi E.
    Noel, Zachary R.
    Watson, Kristin
    Devabhakthuni, Sandeep
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 431 - 445